Sodium potassium-transporting ATPase (NKA)

The Sodium potassium-transporting ATPase (NKA) is a vital transmembrane enzyme found in the plasma membrane of all animal cells (UniProt, 2024). It functions as an ATP-driven pump that actively transports three sodium ions out of the cell and two potassium ions into the cell against their respective concentration gradients (StatPearls, 2023). This activity is fundamental for maintaining the resting membrane potential, regulating cellular osmotic balance, and providing the driving force for the secondary active transport of nutrients and other ions (PubMed, 2021). In clinical medicine, NKA is the primary pharmacological target for cardiac glycosides such as digoxin, which are utilized to manage heart failure and atrial fibrillation by increasing intracellular calcium and enhancing myocardial contractility (NIH, 2022). Beyond its canonical role as an ion transporter, NKA also serves as a scaffold for signaling complexes, influencing pathways related to cell proliferation, apoptosis, and survival (Nature Reviews, 2019). Dysregulation or genetic mutations in NKA subunits are implicated in various pathologies, including essential hypertension, hemiplegic migraine, and the progression of certain cancers (PubMed, 2020).

Other names

Na+/K+-ATPaseSodium-potassium pumpNa,K-ATPaseAdenosine triphosphatase sodium-potassium-activatedATP1A1Sodium pump

The primary mechanism involves the reversible inhibition of the enzyme's alpha subunit, which leads to an increase in intracellular sodium concentration. This rise in sodium reduces the electrochemical gradient that drives the sodium-calcium exchanger (NCX), resulting in an accumulation of intracellular calcium within the sarcoplasmic reticulum, which enhances cardiac muscle contractility (positive inotropic effect) (StatPearls, 2023; NIH, 2022).